Related Experiment Videos
[Current aspects of ACE inhibitor therapy from the cardiologic viewpoint]
1Klinischen Abteilung für Kardiologie, Medizinischen Universitätsklinik Graz.
Insights
Angiotensin-converting enzyme (ACE) inhibitors are effective treatments for hypertension and heart failure, reducing mortality and preventing adverse cardiac remodeling. Their role in other coronary artery diseases is still under investigation.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Established indications for ACE inhibitors include hypertension, heart failure, and acute myocardial infarction.
- Their efficacy in stable/unstable angina and prevention of arteriosclerotic complications is under discussion.
- ACE inhibitors offer comparable antihypertensive effects to other drug classes without adverse metabolic impacts.
Purpose:
- To review the established and potential indications for ACE inhibitors in cardiovascular disease management.
- To compare ACE inhibitors with other antihypertensive agents regarding efficacy and side effect profiles.
- To discuss the role of ACE inhibitors in preventing cardiac remodeling and improving outcomes in specific patient populations.
Summary:
- ACE inhibitors are proven treatments for hypertension and heart failure, reducing morbidity and mortality, particularly in patients with reduced left ventricular ejection fraction.
- They are indicated in acute myocardial infarction for patients with heart failure, depressed left ventricular function, or high-risk profiles.
- ACE inhibitors demonstrate benefits in preventing vascular and cardiac remodeling, with ongoing research into their use for silent ischemia and secondary prevention.
Impact:
- ACE inhibitors represent a cornerstone therapy in managing heart failure and post-myocardial infarction patients, significantly improving survival rates.
- Their favorable metabolic profile makes them a preferred choice for hypertension management in certain patient groups.
- Further research may expand the clinical utility of ACE inhibitors to a broader spectrum of cardiovascular conditions, including stable and unstable angina.
Abstract:
From a cardiologist's view there are several established indications for the use of ACE-inhibitors like hypertension, heart failure and acute myocardial infarction. In other forms of coronary artery disease like stable and unstable angina and prevention of arteriosclerotic complications. ACE-inhibitors are under discussion. As antihypertensives ACE-inhibitors are about equally effective as calcium blockers, betablockers and diuretics without the negative effects on lipid metabolism and insulin sensitivity. Vascular and cardial remodelling are prevented with ACE-inhibitors at least to a certain degree. In heart failure ACE-inhibitors reduce morbidity and mortality, if left ventricular ejection fraction is reduced. In acute myocardial infarction ACE-inhibitors are indicated in overt heart failure, depressed left ventricular function and high-risk-patients. In silent ischaemia and secondary prevention ACE-inhibitors are under discussion.